Mean | Lower bound | Upper bound | ||
---|---|---|---|---|
(95% CI) | (95% CI) | |||
Pharmaceutical cost | Tamiflu | 285 665 | ||
Other | 2 575 322 | 691 010 | 6 401 872 | |
Sub-total | 2 860 986 | 976 675 | 6 687 536 | |
Outpatient cost | Public | 3 415 900 | 2 215 418 | 4 758 469 |
Private | 683 180 | 243 696 | 1 475 125 | |
Sub-total | 4 099 080 | 2 459 114 | 6 233 594 | |
Inpatient cost | Influenza | 1 213 563 | 584 232 | 2 295 357 |
Pneumonia | 9 369 162 | 4 126 879 | 17 933 785 | |
Other | 4 104 548 | 2 248 653 | 6 932 703 | |
Sub-total | 14 687 272 | 6 959 764 | 27 161 845 | |
Direct cost | 21 647 339 | 10 982 153 | 32 312 524 | |
Indirect cost | Employees' own sickness | 202 247 136 | 180 927 219 | 229 780 678 |
Employees' children's sickness | 28 763 862 | 28 763 862 | 28 763 862 | |
Sub-total | 231 010 998 | 200 103 205 | 268 132 650 | |
Total | 252 658 337 | 220 086 635 | 298 627 517 |